Seeking Alpha

Sanofi-Aventis (SNY) discontinues clinical trials of its controversial anti-obesity drug which...

Sanofi-Aventis (SNY) discontinues clinical trials of its controversial anti-obesity drug which had been linked to psychiatric side effects. Separately, Pfizer (PFE) and Merck (MRK) have both abandoned similar drugs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector